{
  "id": 1459,
  "text": "In terms of efficacy, pairwise meta-analyses showed that the 5-year OS rates of CCRT (cisplatin) and CCRT (cisplatin $+ ~ 5$ fluorouracil $^ +$ hydroxyurea) were higher than CCRT (hydroxyrea).There were no significant differences in (1) the 5-year OS rates among the other CCRT regimens tested and (2) the overall response rates and 5-year DFS rate among the evaluated CCRT regimens (Table 37).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: In terms of efficacy, pairwise meta-analyses showed that the 5-year OS rates of CCRT (cisplatin) and CCRT (cisplatin $+ ~ 5$ fluorouracil $^ +$ hydroxyurea) were higher than CCRT (hydroxyrea).There were no significant differences in (1) the 5-year OS rates among the other CCRT regimens tested and (2) the overall response rates and 5-year DFS rate among the evaluated CCRT regimens (Table 37).\n\n<question>: ",
  "ChatGPT_response_0": "根据研究结果，在测试的各种联合化疗方案中，发现在部分方案中，包括使用顺铂的同步放化疗和顺铂与5-氟尿嘧啶和羟基脲的同步放化疗，其5年生存率高于使用羟基脲的同步放化疗。然而，在其他联合化疗方案中，包括总体反应率和5年疾病自由存活率方面，并未发现明显差异。这表明在不同的化疗方案中，可能存在不同的生存率和治疗效果，因此在选择合适的治疗方案时，应根据具体情况综合考虑各项指标。",
  "query": "在测试的各种联合化疗方案中，有无明显的年存活率或总体反应率和5年疾病自由存活率之间的差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在测试的各种联合化疗方案中，有无明显的年存活率或总体反应率和5年疾病自由存活率之间的差异？\n\n<reference text>: In terms of efficacy, pairwise meta-analyses showed that the 5-year OS rates of CCRT (cisplatin) and CCRT (cisplatin $+ ~ 5$ fluorouracil $^ +$ hydroxyurea) were higher than CCRT (hydroxyrea).There were no significant differences in (1) the 5-year OS rates among the other CCRT regimens tested and (2) the overall response rates and 5-year DFS rate among the evaluated CCRT regimens (Table 37).\n\n<reply>: ",
  "response": "根据研究结果，在测试的各种联合化疗方案中，发现在部分方案中，包括使用顺铂的同步放化疗和顺铂与5-氟尿嘧啶和羟基脲的同步放化疗，其5年生存率高于使用羟基脲的同步放化疗。然而，在其他联合化疗方案中，包括总体反应率和5年疾病自由存活率方面，并未发现明显差异。这表明在不同的化疗方案中，可能存在不同的生存率和治疗效果，因此在选择合适的治疗方案时，应根据具体情况综合考虑各项指标。"
}